Aeroflex Neu Fund Raise of ₹13.08 Cr

Aeroflex Neu Other Announcement

Aeroflex Neu filed its Reg 32 statement for the quarter ended September 30, 2026. It reports Rs 795.50 lakh utilised from Rs 6,480 lakh raised via warrants.

Aeroflex Neu Acquisition Worth ₹31 Cr

Aeroflex Neu will buy 55% of Aerolex Cables Private Limited for ₹31.00 Crore in cash. Further tranches will follow under pre-agreed valuation terms.

Value

₹31.00 Cr

Execution

First tranche of 55% within 60 days of board approval; later tranches per definitive agreements

Aeroflex Neu Q2 FY27 Results: Net Loss of ₹3.9 Cr

Aeroflex Neu Ltd reported revenue from operations of ₹35.7 Cr (+3.5% YoY) and a net loss of ₹3.9 Cr for Q2 FY27.

Key figure

Net loss ₹3.9 Cr

Aeroflex Neu Board Meeting Date

Aeroflex Neu will hold a board meeting on October 30, 2026 to consider unaudited standalone and consolidated half-yearly results for the period ended September 2026. The trading window stays closed from October 1 to November 1, 2026.

Aeroflex Neu Acquisition

Aeroflex Neu completed the acquisition of a 51.01% stake in Stilonn Valves and Controls, making it a subsidiary. The deal supports the company's AI Infra and Data Centre initiative.

Aeroflex Neu Annual General Meeting

Aeroflex Neu Limited successfully concluded its Extraordinary General Meeting on October 22, 2026. Members passed all proposed resolutions regarding business and related party transactions.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.